Nuwellis wins U.S. patent for a catheter that improves dialysis and fluid removal therapies.

Nuwellis, Inc. has been granted a U.S. patent for its Dual Lumen Catheter, designed to enhance extracorporeal therapies such as ultrafiltration, dialysis, and continuous renal replacement therapy. The catheter features a stainless-steel coil that prevents collapse under negative pressure and allows length customization without losing structural integrity. This innovation aims to improve blood flow, extend filter life, and offer greater flexibility in treating patients of different sizes, supporting better therapy outcomes. The patent strengthens Nuwellis' position in advancing heart-kidney treatment technologies.